newsfilter
← Latest News
GlobeNewswire·

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,